相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Stage-dependent benefits and risks of pimobendan in mice with genetic dilated cardiomyopathy and progressive heart failure
Miki Nonaka et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Advances in Clinical Cardiology
Andrew H. McNeice et al.
ADVANCES IN THERAPY (2014)
Getting the skinny on thick filament regulation in cardiac muscle biology and disease
Farah Sheikh et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2014)
The β-arrestin-biased ligand TRV120023 inhibits angiotensin II-induced cardiac hypertrophy while preserving enhanced myofilament response to calcium
Michelle M. Monasky et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2013)
Familial dilated cardiomyopathy mutations uncouple troponin I phosphorylation from changes in myofibrillar Ca2 sensitivity
Massimiliano Memo et al.
CARDIOVASCULAR RESEARCH (2013)
2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Clyde W. Yancy et al.
CIRCULATION (2013)
First Clinical Experience With TRV027: Pharmacokinetics and Pharmacodynamics in Healthy Volunteers
David G. Soergel et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2013)
β-Arrestin Regulation of Myosin Light Chain Phosphorylation Promotes AT1aR-mediated Cell Contraction and Migration
Elie Simard et al.
PLOS ONE (2013)
β-Arrestin-biased AT1R stimulation promotes cell survival during acute cardiac injury
Ki-Seok Kim et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2012)
Mouse and computational models link Mlc2v dephosphorylation to altered myosin kinetics in early cardiac disease
Farah Sheikh et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The significance of regulatory light chain phosphorylation in cardiac physiology
Sarah B. Scruggs et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)
Cardiac Myosin Activation: A Potential Therapeutic Approach for Systolic Heart Failure
Fady I. Malik et al.
SCIENCE (2011)
Troglitazone stimulates β-arrestin-dependent cardiomyocyte contractility via the angiotensin II type 1A receptor
Douglas G. Tilley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
Overexpression of Myosin Phosphatase Reduces Ca2+ Sensitivity of Contraction and Impairs Cardiac Function
Hideo Mizutani et al.
CIRCULATION JOURNAL (2010)
Cardiac Myosin Light Chain Kinase Is Necessary for Myosin Regulatory Light Chain Phosphorylation and Cardiac Performance in Vivo
Peiguo Ding et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Selectively Engaging β-Arrestins at the Angiotensin II Type 1 Receptor Reduces Blood Pressure and Increases Cardiac Performance
Jonathan D. Violin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Differential roles of regulatory light chain and myosin binding protein-C phosphorylations in the modulation of cardiac force development
Brett A. Colson et al.
JOURNAL OF PHYSIOLOGY-LONDON (2010)
Familial Dilated Cardiomyopathy Caused by an Alpha-Tropomyosin Mutation The Distinctive Natural History of Sarcomeric Dilated Cardiomyopathy
Neal K. Lakdawala et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
The Angiotensin II Type 1 Receptor Induces Membrane Blebbing by Coupling to Rho A, Rho Kinase, and Myosin Light Chain Kinase
Christina M. Godin et al.
MOLECULAR PHARMACOLOGY (2010)
Identification of cardiac-specific myosin light chain kinase
Jason Y. Chan et al.
CIRCULATION RESEARCH (2008)
Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats
Pal Pacher et al.
NATURE PROTOCOLS (2008)
β-arrestin-biased ligands at seven-transmembrane receptors
Jonathan D. Violin et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation
Cheng-Kun Du et al.
CIRCULATION RESEARCH (2007)
Dilated cardiomyopathy mutant tropomyosin mice develop cardiac dysfunction with significantly decreased fractional shortening and myofilament calcium sensitivity
Sudarsan Rajan et al.
CIRCULATION RESEARCH (2007)
β-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes
Keshava Rajagopal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Characterization and function of MYPT2, a target subunit of myosin phosphatase in heart
Ryuji Okamoto et al.
CELLULAR SIGNALLING (2006)
Acceleration of stretch activation in murine myocardium due to phosphorylation of myosin regulatory light chain
Julian E. Stelzer et al.
JOURNAL OF GENERAL PHYSIOLOGY (2006)
Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKCε phosphorylation
SB Scruggs et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Mechanisms and use of calcium-sensitizing agents in the failing heart
DA Kass et al.
CIRCULATION (2006)
Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I
J Layland et al.
FASEB JOURNAL (2005)
Protein kinase Cε overexpression alters myofilament properties and composition during the progression of heart failure
PH Goldspink et al.
CIRCULATION RESEARCH (2004)
Basal myosin light chain phosphorylation is a determinant of Ca2+ sensitivity of force and activation dependence of the kinetics of myocardial force development
MC Olsson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo
BB Roman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2004)
Mechanisms of action of novel cardiotonic agents
M Endoh
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2002)
Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy
M Kamisago et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)